Last updated: July 29, 2025
Introduction
Patent KR20170067906, filed in South Korea, pertains to innovative pharmaceutical compositions or methods aimed at treating or preventing specific medical conditions. Analyzing its scope, claims, and position within the patent landscape is essential for pharmaceutical stakeholders, including R&D companies, generic manufacturers, and legal professionals. This report offers a comprehensive evaluation of patent claims, their breadth, potential overlaps, and strategic implications within the South Korean patent environment.
Patent Overview
KR20170067906 was published as an application in 2017, with priority likely established around 2016 based on global filing timelines. The patent aims to protect innovative aspects of a drug or formulation—potentially involving novel active compounds, delivery mechanisms, or treatment methods.
While the full specification and claims are necessary for detailed legal analysis, typical patent claim structures for therapeutics include compositions, methods of use, dosage forms, and manufacturing processes.
Scope of the Patent Claims
1. Claim Types and Breadth
-
Product Composition Claims: Likely encompass specific active pharmaceutical ingredients (APIs), their combinations, or formulations designed to target particular diseases. These claims define the scope of protection over the chemical entities or their mixtures.
-
Method Claims: Cover therapeutic or prophylactic methods using the claimed compositions. These may specify method steps, administration regimes, or dosing schedules.
-
Device or Delivery Claims: If pertinent, claims may include novel delivery systems—such as controlled-release formulations or targeted delivery mechanisms.
2. Claim Language and Specificity
-
The scope heavily depends on claim language. Broad claims employing functional language (e.g., “a pharmaceutical composition comprising an effective amount of [compound]”) may offer extensive protection but face challenges if similar prior art exists.
-
Narrow claims specify unique structural features, specific concentration ranges, or particular dosing methods, limiting scope but increasing defensibility.
3. Claim Validity and Enforcement
-
The claims' strength depends on novelty, inventive step, and industrial applicability. Given the competitive pharmaceutical landscape in South Korea, claims should demonstrate an unexpected technical effect or inventive step over prior art.
-
The presence of prior Korean or international patents (e.g., WO or US applications) may influence the validity or scope of KR20170067906.
Patent Landscape Context
1. Prior Art and Patent Family
-
The patent is part of a broader patent family likely encompassing international filings under the Patent Cooperation Treaty (PCT) and regional applications.
-
In the Korean context, the patent landscape is characterized by aggressive patenting in biosciences, often with overlapping claims. Key prior art includes both domestic filings and pioneering international patents from companies like Samsung Biologics, LG Chem, and global pharmaceutical players.
2. Competitor and Co-Patent Activity
-
Similar patents in South Korea focus on biologics, small molecules, or combination patents for similar therapeutic targets.
-
Patent applications from competitors may include overlapping claims; therefore, carving out a unique inventive step or specific formulation is vital for enforceability.
3. Overlap and Potential Infringements
-
The scope of KR20170067906 may overlap with other patents in formulations or methods. A freedom-to-operate investigation should focus on claims relating to active compounds, combinations, and therapeutic methods.
-
Given the dynamic patenting process, existing patents often present a landscape of overlapping rights requiring strategic navigation.
Legal and Strategic Implications
1. Patent Robustness
-
Validation involves analyzing prior art references, including both Korean and international publications, to assess whether the claims are patentable and how broadly they can be enforced.
-
The patent’s enforceability depends on whether these claims captured inventive features sufficiently distinct from prior art.
2. Market Positioning and Lifecycle Management
-
A strong patent scope supports exclusivity for key therapeutic innovations—integral for recouping R&D investments.
-
Patent term adjustments or supplementary protection certificates (SPCs) in South Korea can extend effective market exclusivity, emphasizing the importance of strategic claim drafting.
3. Competitor Challenges and Litigation Strategy
-
Overly broad claims may trigger invalidation lawsuits, whereas narrow claims limit enforcement scope.
-
Companies should monitor emerging patents to preempt infringement by filing continuation applications or utility modifications.
Conclusion
Patent KR20170067906 exemplifies a strategic attempt to carve out protection for a novel pharmaceutical innovation within South Korea’s competitive patent landscape. Its claims likely encompass compositions, methods, or delivery systems, with the legal strength hinging on claim language, prior art distinctions, and inventive step. Maintaining a competitive edge demands ongoing landscape surveillance, strategic claim management, and clear differentiation from existing patents.
Key Takeaways
- The scope of KR20170067906 hinges on claim language—balancing breadth and defensibility is key for robust patent protection.
- Analyzing prior art within Korea and internationally is crucial to evaluate patent strength and avoid infringement.
- Patent landscape navigation requires awareness of overlapping rights, particularly in biologics and small-molecule drugs.
- Strategic patent drafting, including continuation and divisional filings, can fortify market exclusivity.
- Active portfolio management and vigilant monitoring are essential amid a highly innovative and competitive pharmaceutical patent environment.
FAQs
1. How broad are the claims likely to be in KR20170067906?
The claims probably range from broad compositions or methods to narrowly defined formulations—broader claims offering extensive protection may face validity challenges if prior art exists. Precise claim language determines actual scope.
2. How does KR20170067906 compare to international patents in the same field?
It is likely aligned with international patent standards but may have a narrower scope due to regional patent law nuances. A thorough comparison with PCT applications or family patents reveals overlaps and strategic gaps.
3. What can competitors do to avoid infringing this patent?
Competitors can design around claims by modifying active ingredients, dosages, or methods of use, provided these modifications depart from the patented subject matter and do not infringe on the specific claims.
4. How can patent holders strengthen enforcement of KR20170067906?
They should ensure claims are well-aligned with inventive features, keep abreast of evolving prior art, and file continuation applications to extend claim coverage and adapt to competitive threats.
5. What is the relevance of patent landscaping in assessing KR20170067906’s strategic value?
Landscape analysis reveals overlapping patents, potential freedom-to-operate issues, and areas for additional innovation, guiding legal and R&D decisions for maximizing commercial benefits.
References
[1] South Korean Intellectual Property Office (KIPO) database, patent KR20170067906.
[2] WIPO Patent Scope, international patent family related to the application.
[3] Relevant Korean and international patent applications and prior art references.
